Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.233
Companies that carry out R&D in Biotechnology	Main	615
Companies that carry out R&D in Biotechnology	Secondary dwellings	178
Companies that carry out R&D in Biotechnology	Tool	440
%Companies according to biotechnology used: Genetic code	Total	31,7
%Companies according to biotechnology used: Genetic code	Main	40,8
%Companies according to biotechnology used: Genetic code	Secondary dwellings	21,9
%Companies according to biotechnology used: Genetic code	Tool	22,8
%Companies according to biotechnology used: Functional units	Total	38,5
%Companies according to biotechnology used: Functional units	Main	45,5
%Companies according to biotechnology used: Functional units	Secondary dwellings	38,3
%Companies according to biotechnology used: Functional units	Tool	28,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	22,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	28,2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	21,2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	15,7
%Companies according to biotechnology used: Bioprocesses	Total	53,4
%Companies according to biotechnology used: Bioprocesses	Main	46,9
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	57,3
%Companies according to biotechnology used: Bioprocesses	Tool	60,8
%Companies according to biotechnology used: Sub-cellular organisms	Total	8,6
%Companies according to biotechnology used: Sub-cellular organisms	Main	12,5
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	5,2
%Companies according to biotechnology used: Sub-cellular organisms	Tool	4,6
%Companies according to biotechnology used: Bio-computing	Total	22,3
%Companies according to biotechnology used: Bio-computing	Main	31,7
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	15,1
%Companies according to biotechnology used: Bio-computing	Tool	12
%Companies according to biotechnology used: Nanobiotechnology	Total	10,6
%Companies according to biotechnology used: Nanobiotechnology	Main	13,9
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	15,2
%Companies according to biotechnology used: Nanobiotechnology	Tool	4,3
%Companies according to biotechnology used: Other	Total	14,2
%Companies according to biotechnology used: Other	Main	14,8
%Companies according to biotechnology used: Other	Secondary dwellings	17,1
%Companies according to biotechnology used: Other	Tool	12,2
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	46,3
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	63
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	37,1
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	26,6
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	16,2
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	19,7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	16,9
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	11,2
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	32
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	24,2
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	29,9
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	43,9
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	24,6
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	22,5
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	30,1
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	25,3
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	15,5
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	13,7
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	26,8
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	13,4
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	12,9
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	14,3
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	22,6
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	6,9
Personnel in R&D in biotechnology (no. of persons)	Total	13.444
Personnel in R&D in biotechnology (no. of persons)	Main	7.243
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.822
Personnel in R&D in biotechnology (no. of persons)	Tool	4.379
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	7.378
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	4.139
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	1.032
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	2.207
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	6.066
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	3.105
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	790
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	2.171
Personnel in R&D in biotechnology (no. of persons): women	Total	7.501
Personnel in R&D in biotechnology (no. of persons): women	Main	4.255
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	917
Personnel in R&D in biotechnology (no. of persons): women	Tool	2.329
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	4.052
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	2.352
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	542
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	1.158
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	3.450
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	1.903
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	376
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	1.171
Personnel in R&D in biotechnology (FTE)	Total	9.401,9
Personnel in R&D in biotechnology (FTE)	Main	5.696,8
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	1.025,3
Personnel in R&D in biotechnology (FTE)	Tool	2.679,9
Personnel in R&D in biotechnology (FTE): Researchers	Total	5.398,3
Personnel in R&D in biotechnology (FTE): Researchers	Main	3.332,7
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	675,7
Personnel in R&D in biotechnology (FTE): Researchers	Tool	1.389,9
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	4.003,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	2.364,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	349,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	1.290
Personnel in R&D in biotechnology (FTE): women	Total	5.426,2
Personnel in R&D in biotechnology (FTE): women	Main	3.428,5
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	556,8
Personnel in R&D in biotechnology (FTE): women	Tool	1.440,9
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	3.016,4
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	1.924,6
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	360,1
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	731,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	2.409,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	1.503,9
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	196,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	709,2
Internal expenditure on R&D (thousands of euros)	Total	897.333
Internal expenditure on R&D (thousands of euros)	Main	602.520
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	77.601
Internal expenditure on R&D (thousands of euros)	Tool	217.211
1) By nature of the expense: Current expenses	Total	817.409
1) By nature of the expense: Current expenses	Main	541.269
1) By nature of the expense: Current expenses	Secondary dwellings	71.986
1) By nature of the expense: Current expenses	Tool	204.154
1.1) Remuneration to researchers	Total	295.705
1.1) Remuneration to researchers	Main	194.401
1.1) Remuneration to researchers	Secondary dwellings	32.922
1.1) Remuneration to researchers	Tool	68.382
1.2) Remuneration to technicians and assistants	Total	156.853
1.2) Remuneration to technicians and assistants	Main	98.937
1.2) Remuneration to technicians and assistants	Secondary dwellings	11.856
1.2) Remuneration to technicians and assistants	Tool	46.060
1.3) Other current expenses	Total	364.852
1.3) Other current expenses	Main	247.931
1.3) Other current expenses	Secondary dwellings	27.209
1.3) Other current expenses	Tool	89.712
2) By nature of the expense: Capital expenses	Total	79.924
2) By nature of the expense: Capital expenses	Main	61.251
2) By nature of the expense: Capital expenses	Secondary dwellings	5.615
2) By nature of the expense: Capital expenses	Tool	13.057
2.1) Land and buildings	Total	10.272
2.1) Land and buildings	Main	8.482
2.1) Land and buildings	Secondary dwellings	898
2.1) Land and buildings	Tool	892
2.2) Equipment and instruments	Total	56.609
2.2) Equipment and instruments	Main	41.244
2.2) Equipment and instruments	Secondary dwellings	4.323
2.2) Equipment and instruments	Tool	11.043
2.3) Acquisition of specific R+D software	Total	4.839
2.3) Acquisition of specific R+D software	Main	4.254
2.3) Acquisition of specific R+D software	Secondary dwellings	109
2.3) Acquisition of specific R+D software	Tool	476
2.4) Otros productos de propiedad intelectual específicos para I+D	Total	8.203
2.4) Otros productos de propiedad intelectual específicos para I+D	Main	7.271
2.4) Otros productos de propiedad intelectual específicos para I+D	Secondary dwellings	286
2.4) Otros productos de propiedad intelectual específicos para I+D	Tool	647
1.1) By origin of the funds: Own funds	Total	613.097
1.1) By origin of the funds: Own funds	Main	418.567
1.1) By origin of the funds: Own funds	Secondary dwellings	47.014
1.1) By origin of the funds: Own funds	Tool	147.516
1.2) By origin of the funds: From companies	Total	86.085
1.2) By origin of the funds: From companies	Main	44.282
1.2) By origin of the funds: From companies	Secondary dwellings	10.408
1.2) By origin of the funds: From companies	Tool	31.395
1.3) By origin of the funds: Public Administration funds	Total	92.140
1.3) By origin of the funds: Public Administration funds	Main	56.901
1.3) By origin of the funds: Public Administration funds	Secondary dwellings	11.393
1.3) By origin of the funds: Public Administration funds	Tool	23.846
1.4) By origin of the funds: From Universities	Total	853
1.4) By origin of the funds: From Universities	Main	519
1.4) By origin of the funds: From Universities	Secondary dwellings	0
1.4) By origin of the funds: From Universities	Tool	335
1.5) By origin of the funds: From non profit private institutions	Total	4.682
1.5) By origin of the funds: From non profit private institutions	Main	1.965
1.5) By origin of the funds: From non profit private institutions	Secondary dwellings	0
1.5) By origin of the funds: From non profit private institutions	Tool	2.717
1.6) By origin of the funds: Foreign funds	Total	100.476
1.6) By origin of the funds: Foreign funds	Main	80.287
1.6) By origin of the funds: Foreign funds	Secondary dwellings	8.786
1.6) By origin of the funds: Foreign funds	Tool	11.403
Purchase of R&D services in biotechnology (thousands of euros)	Total	85.011
Purchase of R&D services in biotechnology (thousands of euros)	Main	62.516
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	14.617
Purchase of R&D services in biotechnology (thousands of euros)	Tool	7.878
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	54.243
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	36.965
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	11.023
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	6.255
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	30.768
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	25.552
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	3.594
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	1.622
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	39,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	48,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	36,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	27,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	11,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	10,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	15,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	11,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	12,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	12,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	12,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	12,1
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	10,9
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	9,4
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	9,9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	17
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	15
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	11
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Total	15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Main	16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Secondary dwellings	15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Tool	14
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	36
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	42
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	35
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	27
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	47
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	53
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	44
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	39
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	21,8
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	17,6
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	15,6
% Companies that have requested biotechnology patents	Total	17
% Companies that have requested biotechnology patents	Main	25
% Companies that have requested biotechnology patents	Secondary dwellings	16
% Companies that have requested biotechnology patents	Tool	7
Number of patents requested	Total	681
Number of patents requested	Main	473
Number of patents requested	Secondary dwellings	65
Number of patents requested	Tool	144
% Companies with income of an international origin related to biotechnological activities	Total	23
% Companies with income of an international origin related to biotechnological activities	Main	28,9
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	17,9
% Companies with income of an international origin related to biotechnological activities	Tool	17
% Turnover representing income of an international origin related to biotechnological activities	Total	1,6
% Turnover representing income of an international origin related to biotechnological activities	Main	9,4
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	0,1
% Turnover representing income of an international origin related to biotechnological activities	Tool	0,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	56
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	56
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	74
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	49
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	44
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	44
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	26
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	51
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	84
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	82
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	82
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	96
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	14,7
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	17,1
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	0,4
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	0,8
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	0,2
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	15,5
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	1,6
% Income of an international origin related with activities according to the classification: Other	Total	0,6
% Income of an international origin related with activities according to the classification: Other	Main	0,5
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0,2
% Income of an international origin related with activities according to the classification: Other	Tool	1,5